A multicenter, double-blind, double-dummy, randomized controlled trial of the Chinese herbal medicine Linggui granule for patients with asthenospermia
- Conditions
- asthenospermia
- Registration Number
- ITMCTR2200005858
- Lead Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
(1) Study participants must meet the diagnostic criteria of male infertility.
(2) Study participants must meet the diagnostic criteria of AZS.
(3) Men aged 22 to 45 years
(4) The participant must sign informed consent forms
(1)with infertility caused by organic lesions of the reproductive system
(2)with infertility caused by the inability to complete sexual intercourse, including but not limited to erectile dysfunction, ejaculatory disorder
(3)with reproductive system infection, such as chlamydia trachomatis or mycoplasma infection
(4)with abnormal sex hormone
(5)with palpable varicocele
(6)with a history of allergy to any medicine or ingredients used in this study
(7)complicated with mental diseases, malignant tumors, or serious organic diseases
(8)use drugs affecting the experimental study within 3 months
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PR sperm rate;
- Secondary Outcome Measures
Name Time Method PR+NP sperm rate;spouse pregnancy rate;total effective sperm count;sperm DNA fragmentation index;